Skip to Main Content

Print | Bookmark | | Font Size: + |

May 18, 2021Revised 08.26.21

July 2021 HCPCS Updates – New and Revised HCPCS Codes

The following information is based on the July 2021 Healthcare Common Procedure Coding System (HCPCS) file. There are several updates that will be effective July 1, 2021. Please keep in mind, the appearance of a HCPCS code is not an indication of coverage by the DME MAC.

This following list contains added HCPCS codes that will be effective July 1, 2021.

HCPCS DESCRIPTION
J0224 Injection, lumasiran, 0.5 mg
J1951 Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
J9348 Injection, naxitamab-gqgk, 1 mg
J9353 Injection, margetuximab-cmkb, 5 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

The following HCPCS code has description/verbiage changes that will be effective July 1, 2021.

HCPCS DESCRIPTION
J9037 Injection, belantamab mafodotin-blmf, 0.5 mg

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved